We are answering a question that has come in thats a very common one on the topic of GLP-1s
In Phase 3 TRIUMPH-1 data, diarrhea was reported in 25.2% to 34.1% of participants taking retatrutide, constipation in 23.8% to 26.1%, and vomiting in 10.6% to 25.3%, compared with lower rates among participants receiving placebo
In a clinical trial, the highest dose of orforglipron led to 11.2 percent weight loss at 72 weeks
Wegovy: conditions treated Both Contrave and Wegovy are FDA-approved weight loss medications
For most healthy adults, human studies from 2020 to 2024 indicate Pendulum-brand products are generally well tolerated, with mostly mild gastrointestinal complaints that tend to be transient
When sulfur burps occur, several strategies may provide relatively rapid symptomatic relief